{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T16:11:24Z","timestamp":1732032684321},"reference-count":33,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.vaccine.2008.02.041","type":"journal-article","created":{"date-parts":[[2008,3,21]],"date-time":"2008-03-21T04:41:00Z","timestamp":1206074460000},"page":"2242-2252","source":"Crossref","is-referenced-by-count":9,"title":["Two versus three doses of a meningococcal C conjugate vaccine concomitantly administered with a hexavalent DTaP-IPV-HBV\/Hib vaccine in healthy infants"],"prefix":"10.1016","volume":"26","author":[{"given":"Heinz-J.","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin Simone","family":"Steul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Borkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ceddia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Ypma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Knuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2008.02.041_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/MMBR.46.2.162-190.1982","article-title":"The meningococcus and mechanisms of pathogenicity","volume":"46","author":"DeVoe","year":"1982","journal-title":"Microbiol Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2008.02.041_bib2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"18","key":"10.1016\/j.vaccine.2008.02.041_bib3","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.041_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0950268898001848","article-title":"Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993\u20131996","volume":"122","author":"Connolly","year":"1999","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.02.041_bib5","unstructured":"Centers for Disease Control and Prevention. Control and prevention of meningococcal disease and control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR; 1997 46(RR-5):1\u201321."},{"key":"10.1016\/j.vaccine.2008.02.041_bib6","first-page":"7025","article-title":"A review of vaccine research and development: meningococcal disease","volume":"24","author":"Girard","year":"2006","journal-title":"Vaccine"},{"issue":"20\u201322","key":"10.1016\/j.vaccine.2008.02.041_bib7","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/S0264-410X(00)00528-4","article-title":"Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age","volume":"19","author":"Bramley","year":"2001","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2008.02.041_bib8","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration and implementation of an immunization campaign against meningococcal serogroups C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.02.041_bib9","unstructured":"National Advisory Committee on Immunization. Supplementary statement on conjugate meningococcal vaccines. Can Commun Dis Rep;2003 29:10\u201311."},{"key":"10.1016\/j.vaccine.2008.02.041_bib10","unstructured":"Health Protection Agency. Routine childhood immunisation schedule (Available at: http:\/\/www.hpa.org.uk) (Accessed February 2007)."},{"key":"10.1016\/j.vaccine.2008.02.041_bib11","unstructured":"Centers for Disease Control and Prevention. Recommended immunization schedule for persons aged 0\u20136 years; United States 2007 (Available at: http:\/\/www.cdc.gov\/vaccines\/recs\/schedules\/downloads\/child\/2007\/child-schedule-bw-print.pdf) (Accessed February 2008)."},{"issue":"6","key":"10.1016\/j.vaccine.2008.02.041_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.inf.0000222413.47344.23","article-title":"The use of combination vaccines has improved timeliness of vaccination in children","volume":"25","author":"Kalies","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.02.041_bib13","unstructured":"European Medicines Agency. Press Release. European Medicines Agency recommends suspension of Hexavac; 2005 (Available at http:\/\/www.emea.europa.eu\/pdfs\/human\/press\/pr\/29736905en.pdf) (Accessed February 2008)."},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.041_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/CDLI.5.4.479-485.1998","article-title":"A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses","volume":"5","author":"Granoff","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.02.041_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diag Lab Immunol"},{"issue":"21","key":"10.1016\/j.vaccine.2008.02.041_bib16","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1001\/jama.283.21.2795","article-title":"Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants","volume":"283","author":"Maclennan","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2008.02.041_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jmv.1890170306","article-title":"Immune responses to late booster doses of hepatitis B vaccine","volume":"17","author":"Jilg","year":"1985","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.041_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1542\/peds.107.4.771","article-title":"Adolescent hepatitis B immunization: making it simpler","volume":"107","author":"Poland","year":"2001","journal-title":"Pediatrics"},{"issue":"9431","key":"10.1016\/j.vaccine.2008.02.041_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2008.02.041_bib20","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1128\/IAI.71.10.5549-5555.2003","article-title":"Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United Kingdom","volume":"71","author":"Borrow","year":"2003","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.02.041_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.inf.0000151029.58752.27","article-title":"Lack of bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine","volume":"24","author":"Snape","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"9355","key":"10.1016\/j.vaccine.2008.02.041_bib22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0140-6736(03)12441-5","article-title":"Conjugate Hib vaccines","volume":"361","author":"Steinhoff","year":"2003","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2008.02.041_bib23","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2006-01-009282","article-title":"CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen specific memory B cells","volume":"108","author":"Kelly","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.vaccine.2008.02.041_bib24","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/01.inf.0000145427.19167.35","volume":"23","author":"Tejedor","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.02.041_bib25","unstructured":"Data on file: Novartis Vaccines study number V14P38E1."},{"issue":"5","key":"10.1016\/j.vaccine.2008.02.041_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/adc.85.5.391","article-title":"Safety of a new conjugate meningococcal C vaccine in infants","volume":"85","author":"Lakshman","year":"2001","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.vaccine.2008.02.041_bib27","first-page":"243","article-title":"Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study","volume":"25","author":"Halperin","year":"2002","journal-title":"Clin Invest Med"},{"issue":"19","key":"10.1016\/j.vaccine.2008.02.041_bib28","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.vaccine.2008.02.041_bib29","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jama.283.14.1826","article-title":"Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine?","volume":"283","author":"MacDonald","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.041_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of three different meningococcal C conjugate vaccines to induce immunological memory after a single dose in UK toddlers","volume":"183","author":"Richmond","year":"2001","journal-title":"J Infect Dis"},{"issue":"24","key":"10.1016\/j.vaccine.2008.02.041_bib31","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/S0264-410X(00)00050-5","article-title":"Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial","volume":"18","author":"Choo","year":"2000","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2008.02.041_bib32","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1001\/jama.292.20.2491","article-title":"Effectiveness of a mass immunization campaign using serogroup C meningococcal vaccine","volume":"292","author":"De Wals","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.02.041_bib33","unstructured":"Data on file: Novartis Vaccines study number V14P17."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08002272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08002272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T05:41:05Z","timestamp":1684302065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08002272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":33,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0264410X08002272"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.02.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}